eCOA Solutions
-
End-To-End Digital Therapeutics Studies Powered By Technology
2/2/2023
Curebase offers a variety of decentralized study models designed and tested for any type of DTx trial.
-
End-To-End Diagnostic Studies Powered By Technology
12/16/2022
Learn why Curebase is the only partner you need to run faster, more efficient real-world diagnostics studies from start to finish.
-
One eCOA Solution For All Protocol Requirements
3/31/2022
Improve trial efficiency, quality, and safety by accessing Clinical ink's large assortment of clinical outcomes assessments for a wide range of phases and therapeutic areas.
-
Unlock Additional Capabilities For Your Next Clinical Trial
2/21/2023
Gain insight on how a single point of entry can improve patient and site experience by offering best-in-class eCOA, consent management, and patient engagement solutions.
-
Streamlined Deployment And Patient Data Collection
7/31/2025
Navigate the inherent complexities, infinite variables, and constant changes that define life-sustaining studies with confidence using a patient-centric platform.
-
eCOA / ePRO
9/16/2024
Empower participants, clinicians, and observers. Enable convenient and accurate outcome reporting, enhancing data quality and study efficiency with electronic patient reported outcomes (ePRO) and electronic clinical outcome assessments (eCOA).
-
Optimizing The Path To RSV Vaccine Approval
2/20/2024
Vaccine trials pose unique challenges; that's why sponsors and CROs trust us to navigate complexities and capture audit-ready, high-quality evidence required to get new vaccines to patients.
-
eCOA Questionnaire Designs To Improve Pediatric Experiences
5/23/2022
Get the flexibility to customize questionnaire design with illustrations that are a better fit for population preferences, especially in young patient populations completing outcome assessments.
-
Clinical Trial Technology Solutions & Services Tailored For Phase I Clinical Trials
3/19/2024
Phase I clinical trials need technological solutions that support rapid implementation and end-to-end processes. Signant’s unified eClinical platform provides the perfect partner for Phase I research.
-
How Can Phase 1 Trials Employ eClinical Solutions?
1/8/2024
Uncover how this unified platform is helping sponsors and CROs generate high-quality data, accelerate trials, and rapidly scale to Phase 2 and beyond.